• 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • 2021-03
  • br Jensen LS Overgaard C Garne JP Boggild H Fonager


    [2] Jensen LS, Overgaard C, Garne JP, Boggild H, Fonager K. The impact of prior psychiatric medical treatment on return to work after Necrostatin1 diagnosis of breast cancer: a registry based study. Scand J Publ Health 2017. 1403494817722291. [3] Johnsson A, Fornander T, Rutqvist LE, Olsson M. Work status and life changes in the first year after breast cancer diagnosis. Work 2011;38(4):337e46. [4] Noeres D, Park-Simon TW, Grabow J, et al. Return to work after treatment for primary breast cancer over a 6-year period: results from a prospective study comparing patients with the general population. Support Care Canc 2013;21(7):1901e9.
    [5] Eaker S, Wigertz A, Lambert PC, et al. Breast cancer, sickness absence, income and marital status. A study on life situation 1 year prior diagnosis compared to 3 and 5 years after diagnosis. PLoS One 2011;6(3):e18040. [6] Lundh MH, Lampic C, Nordin K, et al. Sickness absence and disability pension following breast cancer - a population-based matched cohort study. Breast 2014;23(6):844e51.
    [9] Balak F, Roelen CA, Koopmans PC, Ten Berge EE, Groothoff JW. Return to work after early-stage breast cancer: a cohort study into the effects of treatment and cancer-related symptoms. J Occup Rehabil 2008;18(3):267e72.
    [10] Carlsen K, Jensen AJ, Rugulies R, et al. Self-reported work ability in long-term breast cancer survivors. A population-based questionnaire study in Denmark.  Acta Oncol 2013;52(2):423e9.
    [11] Von Ah D, Storey S, Crouch A, Johns SA, Dodson J, Dutkevitch S. Relationship of self-reported attentional fatigue to perceived work ability in breast cancer survivors. Cancer Nurs 2017;40(6):464e70. [12] Fantoni SQ, Peugniez C, Duhamel A, Skrzypczak J, Frimat P, Leroyer A. Factors related to return to work by women with breast cancer in northern France. J Occup Rehabil 2010;20(1):49e58.
    [15] National breast cancer quality register of Sweden. 2014. Annual report. [In Swedish],
    [17] Sobin L, Gospodarowicz M, Wittekind C. TNM classification of malignant tu-mours. seventh ed. Hoboken: Wiley; 2009. [18] Allignol A, Schumacher M, Beyersmann J. Empirical transition matrix of multi-state models: the etm package. J Stat Software 2011;38(4):1e15. [19] Crowther MJ, Lambert PC. Parametric multistate survival models: flexible modelling allowing transition-specific distributions with application to esti-mating clinically useful measures of effect differences. Stat Med 2017;36(29): 4719e42.
    [20] Damkjaer LH, Deltour I, Suppli NP, et al. Breast cancer and early retirement: associations with disease characteristics, treatment, comorbidity, social po-sition and participation in a six-day rehabilitation course in a register-based study in Denmark. Acta Oncol 2011;50(2):274e81.
    [23] Wang L, Hong BY, Kennedy SA, et al. Predictors of unemployment after breast cancer surgery: a systematic review and meta-analysis of observational studies. J Clin Oncol Jun 20 2018;36(18):1868e79.
    [24] Ng HS, Koczwara B, Roder DM, Niyonsenga T, Vitry AI. Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis. Med J Aust 2018;208(1):24e8. [25] Suppli NP, Johansen C, Christensen J, Kessing LV, Kroman N, Dalton SO. Increased risk for depression after breast cancer: a nationwide population-based cohort study of associated factors in Denmark, 1998-2011. J Clin Oncol 2014;32(34):3831e9.
    [27] Lu D, Andersson TM, Fall K, et al. Clinical diagnosis of mental disorders immediately before and after cancer diagnosis: a nationwide matched cohort study in Sweden. Jama Oncol 2016;2(9):1188e96. [28] Hartung TJ, Brahler E, Faller H, et al. The risk of being depressed is significantly higher in cancer patients than in the general population: prevalence and severity of depressive symptoms across major cancer types. Eur J Cancer 2017;72:46e53.
    [31] Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C. Increased incidence of stroke in women with breast cancer. Eur J Cancer 2005;41(3):423e9. [32] Boerman LM, Maass S, van der Meer P, et al. Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: a cross-sectional study. Eur J Cancer 2017;81:56e65.
    [33] Gulati M, Mulvagh SL. The connection between the breast and heart in a woman: breast cancer and cardiovascular disease. Clin Cardiol 2018;41(2): 253e7.
    [34] Chen JY, Ballou SP. The effect of antiestrogen agents on risk of autoimmune disorders in patients with breast cancer. J Rheumatol 2015;42(1):55e9. [35] Yang H, Brand JS, Li J, et al. Risk and predictors of psoriasis in patients with breast cancer: a Swedish population-based cohort study. BMC Med 2017;15(1):154.